Filing Details

Accession Number:
0000930413-11-007456
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-18 08:48:52
Reporting Period:
2011-11-16
Filing Date:
2011-11-18
Accepted Time:
2011-11-18 08:48:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
316253 Enzo Biochem Inc ENZ Services-Medical Laboratories (8071) 132866202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
903568 Elazar Rabbani C/O Enzo Biochem, Inc.
527 Madison Avenue
New York, NY 10022
Ceo And Secretary Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 600 $2.28 2,100,889 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 6,600 $2.28 2,107,489 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 5,700 $2.29 2,113,189 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 3,600 $2.29 2,116,789 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 2,800 $2.30 2,119,589 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 100 $2.30 2,119,689 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 600 $2.30 2,120,289 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes (i) 239,000 shares of Common Stock issuable upon the exercise of options which are exercisable within 60 days from the date hereof, (ii) 5,547 shares of Common Stock held in the name of the Reporting Person as custodian for certain of his children, (iii) 22,115 shares of Common Stock held in the name of the Reporting Person's wife as custodian for certain of their children, (iv) an aggregate of 5,100 shares of Common Stock held in the name of the Reporting Person's children and (v) 12,502 shares of Common Stock held in the Company's 401(k) plan.